3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Carcinoma, Non-Small-Cell Lung
96
Lung Neoplasms
38
Neoplasms
10
Mesothelioma, Malignant
9
Mesothelioma
8
Adenocarcinoma of Lung
8
Small Cell Lung Carcinoma
7
Neoplasm Metastasis
7
Thoracic Neoplasms
5
Recurrence
5
Lung Diseases
5
Carcinoma
5
Respiratory Tract Neoplasms
4
Carcinoma, Bronchogenic
4
Brain Neoplasms
4
Respiratory Tract Diseases
3
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Neoplasms by Site
3
Neoplasms by Histologic Type
3
NSCLC
3
Head and Neck Neoplasms
3
Bronchial Neoplasms
3
Adenocarcinoma, Bronchiolo-Alveolar
3
Adenocarcinoma
3
Triple Negative Breast Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Non-small-cell Lung Cancer With Somatic EGFR Mutations
2
Neoplasms, Nerve Tissue
2
Melanoma
2
Interventions
amatuximab
1
Pemetrexed
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Severe combined immunodeficiency with sensitivity to ionizing radiation
×
Pemetrexed
×
Clear all
NCT02357147
2020-03-17
ARTEMIS
Morphotek
Phase 2
Terminated
124 enrolled
10 charts